Intratracheal Administration of Autologous Bone Marrow-Derived Cells Ameliorates Monocrotaline-Induced Pulmonary Vessel Remodeling and Lung Inflammation in Rats

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Lung

• Publication date

  2018-04-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1007/s00408-017-0075-5PMID 29264652
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms

  2015influential reference
• Endothelial NO-Synthase Gene-Enhanced Progenitor Cell Therapy for Pulmonary Arterial Hypertension: The PHACeT Trial.

  2015cited by this paper
• Pulmonary Macrophage Transplantation Therapy

  2014cited by this paper
• Effects of different mesenchymal stromal cell sources and delivery routes in experimental emphysema

  2014cited by this paper
• Intratracheal administration of cyclooxygenase-1-transduced adipose tissue-derived stem cells ameliorates monocrotaline-induced pulmonary hypertension in rats.

  2014cited by this paper
• Intravenous and Intratracheal Mesenchymal Stromal Cell Injection in a Mouse Model of Pulmonary Emphysema

  2013cited by this paper
• Immune and inflammatory cell involvement in the pathology of idiopathic pulmonary arterial hypertension.

  2012cited by this paper
• The monocrotaline model of pulmonary hypertension in perspective.

  2012influential reference
• Stem cells and cell therapies in lung biology and lung diseases.

  2011cited by this paper
• Protective and pathogenic functions of macrophage subsets

  2011influential reference
• Perivascular T-cell infiltration leads to sustained pulmonary artery remodeling after endothelial cell damage.

  2011cited by this paper
• Mouse Bone Marrow-Derived Mesenchymal Stromal Cells Turn Activated Macrophages into a Regulatory-Like Profile

  2010cited by this paper
• Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy.

  2010cited by this paper
• Prevention of Pulmonary Hypertension by Angiotensin-Converting Enzyme 2 Gene Transfer

  2009cited by this paper
• Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.

  2009cited by this paper
• Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension.

  2009cited by this paper
• Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury.

  2009cited by this paper
• Bone marrow stromal cells attenuate lung injury in a murine model of neonatal chronic lung disease.

  2009cited by this paper
• Bone marrow progenitor cells contribute to repair and remodeling of the lung and heart in a rat model of progressive pulmonary hypertension

  2008cited by this paper
• Paracrine Factors of Mesenchymal Stem Cells Recruit Macrophages and Endothelial Lineage Cells and Enhance Wound Healing

  2008cited by this paper
• The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry

  2008cited by this paper
• Safety and efficacy of autologous endothelial progenitor cells transplantation in children with idiopathic pulmonary arterial hypertension: Open‐label pilot study

  2008cited by this paper
• Intrapulmonary Delivery of Bone Marrow-Derived Mesenchymal Stem Cells Improves Survival and Attenuates Endotoxin-Induced Acute Lung Injury in Mice1

  2007cited by this paper
• Targeted cell replacement with bone marrow cells for airway epithelial regeneration.

  2007cited by this paper
• Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice

  2007cited by this paper
• Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial.

  2007cited by this paper
• Interleukin-10 Expression Mediated by an Adeno-Associated Virus Vector Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats

  2007cited by this paper
• Intratracheal mesenchymal stem cell administration attenuates monocrotaline-induced pulmonary hypertension and endothelial dysfunction.

  2007cited by this paper
• Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs

  2006cited by this paper
• Rescue of Monocrotaline-Induced Pulmonary Arterial Hypertension Using Bone Marrow–Derived Endothelial-Like Progenitor Cells: Efficacy of Combined Cell and eNOS Gene Therapy in Established Disease

  2005cited by this paper
• Transplantation of Endothelial Progenitor Cells into the Lung to Alleviate Pulmonary Hypertension in Dogs

  2004cited by this paper
• Hemoglobin Scavenger Receptor CD163 Mediates Interleukin-10 Release and Heme Oxygenase-1 Synthesis: Antiinflammatory Monocyte-Macrophage Responses In Vitro, in Resolving Skin Blisters In Vivo, and After Cardiopulmonary Bypass Surgery

  2004cited by this paper
• Isolation of Putative Progenitor Endothelial Cells for Angiogenesis

  1997cited by this paper
• Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.

  1994cited by this paper
• Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated rats.

  1989influential reference
• THE DEVELOPMENT OF FIBROBLAST COLONIES IN MONOLAYER CULTURES OF GUINEA‐PIG BONE MARROW AND SPLEEN CELLS

  1970cited by this paper

• Carbenoxolone decreases monocrotaline-induced pulmonary inflammation and pulmonary arteriolar remodeling in rats by decreasing the expression of connexins in T lymphocytes

  2019cites this paper
• Intracerebroventricular administration of bone marrow-derived cells attenuates angiotensin II-initiated neurogenic hypertension in rats

  2018cites this paper